(19)
(11) EP 1 023 279 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
13.08.2003 Bulletin 2003/33

(45) Mention of the grant of the patent:
16.04.2003 Bulletin 2003/16

(21) Application number: 98908534.5

(22) Date of filing: 12.02.1998
(51) International Patent Classification (IPC)7: C07D 303/46, C07D 303/34, C07C 253/30, A61K 31/275
(86) International application number:
PCT/US9802/749
(87) International publication number:
WO 9803/4584 (13.08.1998 Gazette 1998/32)

(54)

COMPOUNDS AND METHOD FOR PREPARING SUBSTITUTED 4-PHENYL-4-CYANOCYCLOHEXANOIC ACIDS

VERBINDUNGEN UND VERFAHREN ZUR HERSTELLUNG SUBSTITUIERTER 4-PHENYL-4-CYANOCYCLOHEXANSÄUREN

COMPOSES ET PROCEDE DE PREPARATION D'ACIDES 4-PHENYL-4-CYANOCYCLOHEXANOIQUES SUBSTITUES

(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
RO SI

(30) Priority: 12.02.1997 US 37608 P

(43) Date of publication of application:
02.08.2000 Bulletin 2000/31

(60) Divisional application:
02078056.5 / 1295869
02078057.3 / 1327627

(73) Proprietor: SmithKline Beecham Corporation
Philadelphia, PA 19103 (US)

(72) Inventors:
  • ALLEN, Andrew
    Exton, PA 19341 (US)
  • DIEDERICH, Ann, Marie
    Downingtown, PA 19335 (US)
  • LIU, Li
    Collegeville, PA 19426 (US)
  • MENDELSON, Wilford
    King of Prussia, PA 19406 (US)

(74) Representative: Waters, David Martin, Dr. et al
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)


(56) References cited: : 
GB-A- 2 144 422
US-A- 5 602 173
 US-A- 5 552 438
   
  • SCHWETLICK K. ET AL.: 'Organikum', 1990, DVW, BERLIN
  • BEYER H., WALTER W.: 'Lehrbuch der organischen Chemie', 1991, S. HIRZEL VERLAG, STUTTGART
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).